The secondary prevention of ischaemic heart disease in Spain. A systematic review of observational studies

To describe the use of ischaemic heart disease (IHD) secondary prevention measures in the Spanish National Health System. Systematic review of observational studies with information on the use of preventive treatment and measures in the prevention of secondary IHD. Primary care and specialised out-p...

Full description

Saved in:
Bibliographic Details
Published in:Atención primaria 2006-09, Vol.38 (5), p.250-257
Main Authors: Sanfélix, Gabriel, Peiró, Salvador, Gosalbes Soler, Victoria, Cervera Casino, Pedro
Format: Article
Language:Spanish
Subjects:
Cardiovascular Agents - therapeutic use
Clinical Trials as Topic
Epidemiologic Studies
Humans
Myocardial Ischemia - drug therapy
Myocardial Ischemia - prevention & control
Spain
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To describe the use of ischaemic heart disease (IHD) secondary prevention measures in the Spanish National Health System. Systematic review of observational studies with information on the use of preventive treatment and measures in the prevention of secondary IHD. Primary care and specialised out-patient clinics. Medline search and complementary searches of studies published between 1995 and 2004 with a description of the use secondary prevention measures on hospital discharge or in the follow up after discharge. A total of 125 references were found after the MEDLINE search, 13 of which were selected after an independent review by 2 researchers. The complementary sources provided 9 more studies giving a total of 22. One researcher extracted information on the characteristics of the study and the results variables, which were independently verified by a second evaluator. RESULTS. In the 22 studies found, a high level of variation was shown in the different treatment rates: anti-aggregants (at discharge, 72%-97.1%; follow-up, 46.4%-93.8%); beta-blockers (at discharge, 29%-68.3%; follow-up, 22.4%-59.0%); drugs with action on the renin-angiotensin system (at discharge, 16.2%-52.2%; follow-up, 6.1%-53.1%); lipid lowering drugs (at discharge, 6.7%-88.7%; follow-up, 24.5%-89.5%). The treatment rates showed a progressive improvement over time during the period studied. In the period 1994-2003 treatment rates in the secondary prevention of IHD have increased, although there is still much room for improvement.
ISSN:0212-6567
1578-1275